These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 39062463)

  • 1. Molecular Mechanisms and Potential Antiviral Strategies of Liquid-Liquid Phase Separation during Coronavirus Infection.
    Wang Y; Zhou L; Wu X; Yang S; Wang X; Shen Q; Liu Y; Zhang W; Ji L
    Biomolecules; 2024 Jun; 14(7):. PubMed ID: 39062463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid-liquid phase separation in innate immunity.
    Liu D; Yang J; Cristea IM
    Trends Immunol; 2024 Jun; 45(6):454-469. PubMed ID: 38762334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of phase separation and antiviral activity of Cactin by glycolytic enzyme PGK via phosphorylation in
    Chen D; Shi C; Xu W; Rong Q; Wu Q
    mBio; 2024 Apr; 15(4):e0137823. PubMed ID: 38446061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of the Antiviral Immune Response and Its Circumvention by Coronaviruses.
    Liu P; Hong Y; Yang B; Shrestha P; Sajjad N; Chen JL
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32961897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection.
    Totura AL; Whitmore A; Agnihothram S; Schäfer A; Katze MG; Heise MT; Baric RS
    mBio; 2015 May; 6(3):e00638-15. PubMed ID: 26015500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular arms race between host innate antiviral response and emerging human coronaviruses.
    Wong LY; Lui PY; Jin DY
    Virol Sin; 2016 Feb; 31(1):12-23. PubMed ID: 26786772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight into the mechanisms of coronaviruses evading host innate immunity.
    Yao T; Foo C; Zheng G; Huang R; Li Q; Shen J; Wang Z
    Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166671. PubMed ID: 36858323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of STING Signaling Pathway Effectively Blocks Human Coronavirus Infection.
    Liu W; Reyes HM; Yang JF; Li Y; Stewart KM; Basil MC; Lin SM; Katzen J; Morrisey EE; Weiss SR; You J
    J Virol; 2021 May; 95(12):. PubMed ID: 33789998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immune sensing of coronavirus and viral evasion strategies.
    Kasuga Y; Zhu B; Jang KJ; Yoo JS
    Exp Mol Med; 2021 May; 53(5):723-736. PubMed ID: 33953325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Nucleocapsid Proteins of SARS-CoV-2 and Its Close Relative Bat Coronavirus RaTG13 Are Capable of Inhibiting PKR- and RNase L-Mediated Antiviral Pathways.
    LeBlanc K; Lynch J; Layne C; Vendramelli R; Sloan A; Tailor N; Deschambault Y; Zhang F; Kobasa D; Safronetz D; Xiang Y; Cao J
    Microbiol Spectr; 2023 Jun; 11(3):e0099423. PubMed ID: 37154717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms and cellular functions of liquid-liquid phase separation during antiviral immune responses.
    Yang S; Shen W; Hu J; Cai S; Zhang C; Jin S; Guan X; Wu J; Wu Y; Cui J
    Front Immunol; 2023; 14():1162211. PubMed ID: 37251408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular nucleic acid-binding protein restricts SARS-CoV-2 by regulating interferon and disrupting RNA-protein condensates.
    Chen Y; Lei X; Jiang Z; Humphries F; Parsi KM; Mustone NJ; Ramos I; Mutetwa T; Fernandez-Sesma A; Maehr R; Caffrey DR; Fitzgerald KA
    Proc Natl Acad Sci U S A; 2023 Nov; 120(47):e2308355120. PubMed ID: 37963251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How does severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) achieve immune evasion?: A narrative review.
    Bai Y; Ning K
    Medicine (Baltimore); 2024 Apr; 103(16):e37780. PubMed ID: 38640329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity.
    Gu W; Gan H; Ma Y; Xu L; Cheng ZJ; Li B; Zhang X; Jiang W; Sun J; Sun B; Hao C
    Virol J; 2022 Mar; 19(1):49. PubMed ID: 35305698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunologic response to severe acute respiratory syndrome coronavirus 2.
    Le NK; Kaman K; Martin HC; Mullur J; Stenehjem KK; Coomar L; Bahar B; Dutta M; Izurieta R; Brooks JP
    Allergy Asthma Proc; 2021 Nov; 42(6):495-505. PubMed ID: 34871157
    [No Abstract]   [Full Text] [Related]  

  • 17. Liquid-liquid phase separation of nucleocapsid proteins during SARS-CoV-2 and HIV-1 replication.
    Chau BA; Chen V; Cochrane AW; Parent LJ; Mouland AJ
    Cell Rep; 2023 Jan; 42(1):111968. PubMed ID: 36640305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses.
    Kehrer T; García-Sastre A; Miorin L
    J Interferon Cytokine Res; 2021 Jun; 41(6):205-219. PubMed ID: 34161170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences and similarities between innate immune evasion strategies of human coronaviruses.
    Hoenigsperger H; Sivarajan R; Sparrer KM
    Curr Opin Microbiol; 2024 Jun; 79():102466. PubMed ID: 38555743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways.
    Oh SJ; Shin OS
    J Microbiol; 2022 Mar; 60(3):290-299. PubMed ID: 35122601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.